4//SEC Filing
Meeker David P 4
Accession 0001104659-25-009285
CIK 0001649904other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 9:25 PM ET
Size
15.6 KB
Accession
0001104659-25-009285
Insider Transaction Report
Form 4
Meeker David P
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-01+14,125→ 194,205 total - Sale
Common Stock
2025-02-04$59.43/sh−4,278$254,242→ 189,927 total - Exercise/Conversion
Restricted Stock Units
2025-02-01−14,125→ 28,250 total→ Common Stock (14,125 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]Includes 5,475 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001385155
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 9:25 PM ET
- Size
- 15.6 KB